Regulation of neurosteroid allopregnanolone biosynthesis in the rat spinal cord by glycine and the alkaloidal analogs strychnine and gelsemine

Neuroscience

Volumn 153, Issue 1, 2008, Pages 154-161

  Venard, C ^a   Boujedaini, N ^b   Belon, P ^b   Mensah Nyagan, A G ^a   Patte Mensah, C ^a  

^a CNRS   (France)

^b Boiron   (France)

Author keywords

glycinergic system; neurosteroid and neurotransmitter; neurosteroidogenesis regulator; steroidogenesis in nerve cells; steroids and nervous system; structure activity relationship

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ALKALOID DERIVATIVE; GELSEMINE; GLYCINE; NEUROSTEROID; STRYCHNINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; MALE; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; STRUCTURE ACTIVITY RELATION; UPREGULATION;

ALKALOIDS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; DRUG SYNERGISM; GLYCINE; GLYCINE AGENTS; MALE; MOLECULAR STRUCTURE; NEUROGLIA; NEURONS; ORGAN CULTURE TECHNIQUES; PREGNANOLONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLYCINE; SPINAL CORD; STRYCHNINE;

EID: 41949118170     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.02.009     Document Type: Article

References (58)

1. Akwa Y., Purdy R.H., Koob G.F., and Britton K.T. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res 106 (1999) 119-125
2. Barbaccia M.L., Concas A., Serra M., and Biggio G. Stress and neurosteroids in adult and aged rats. Exp Gerontol 33 (1998) 697-712
3. Baulieu E.E., Robel P., and Schumacher M. Neurosteroids: a new regulatory function in the nervous system. In: Baulieu E.E., Robel P., and Schumacher M. (Eds) (1999), Humana Press, Totowa, NJ 1-377
4. Belelli D., and Lambert J.J. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci 6 (2005) 565-575
5. Betz H., and Laube B. Glycine receptors: recent insights into their structural organization and functional diversity. J Neurochem 97 (2006) 1600-1610
6. Brinton R.D., and Wang J.M. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent. Curr Alzheimer Res 3 (2006) 185-190
7. Carrasco M.A., Castro P.A., Sepulveda F.J., Cuevas M., Tapia J.C., Izaurieta P., van Zundert B., and Aguayo L.G. Anti-homeostatic synaptic plasticity of glycine receptor function after chronic strychnine in developing cultured mouse spinal neurons. J Neurochem 100 (2007) 1143-1154
8. Compagnone N.A., and Mellon S.H. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc Natl Acad Sci U S A 95 (1998) 4678-4683
9. Do-Rego J.L., Mensah-Nyagan A.G., Beaujean D., Vaudry D., Sieghart W., Luu-The V., Pelletier G., and Vaudry H. gamma-Aminobutyric acid, acting through gamma-aminobutyric acid type A receptors, inhibits the biosynthesis of neurosteroids in the frog hypothalamus. Proc Natl Acad Sci U S A 97 (2000) 13925-13930
10. Dubrovsky B. Neurosteroids, neuroactive steroids, and symptoms of affective disorders. Pharmacol Biochem Behav 84 (2006) 644-655
11. Fossat P., Sibon I., Le Masson G., Landry M., and Nagy F. L-type calcium channels and NMDA receptors: a determinant duo for short-term nociceptive plasticity. Eur J Neurosci 25 (2007) 127-135
12. Gibbs T.T., Yagoubi N., Weaver C.E., Park-Chung M., Russek S.J., and Farb D.H. Modulation of ionotropic glutamate receptors by neuroactive steroids. In: Baulieu E.E., Robel P., and Schumacher M. (Eds). Neurosteroids: a new regulatory function in the nervous system (1999), Humana Press, Totowa, NJ 167-190
13. Grecian S., and Aube J. Double conjugate addition of a nitropropionate ester to a quinone monoketal: synthesis of an advanced intermediate to (+/-)-gelsemine. Org Lett 9 (2007) 3153-3156
14. Griffin L.D., Gong W., Verot L., and Mellon S.H. Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat Med 10 (2004) 704-711
15. Guarneri P., Guarneri R., Cascio C., Piccoli F., and Papadopoulos V. gamma-Aminobutyric acid type A/benzodiazepine receptors regulate rat retina neurosteroidogenesis. Brain Res 683 (1995) 65-72
16. Haines D.E., Mihailoff G.A., and Yezierski R.P. The spinal cord. In: Haines D.E. (Ed). Fundamental Neuroscience (1997), Churchill Livingstone Inc, New York, NY 129-141
17. Hosie A.M., Wilkins M.E., da Silva H.M., and Smart T.G. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444 (2006) 486-489
18. Jiang P., Yang C.X., Wang Y.T., and Xu T.L. Mechanisms of modulation of pregnanolone on glycinergic response in cultured spinal dorsal horn neurons of rat. Neuroscience 141 (2006) 2041-2050
19. Kibaly C., Patte-Mensah C., and Mensah-Nyagan A.G. Molecular and neurochemical evidence for the biosynthesis of dehydroepiandrosterone in the adult rat spinal cord. J Neurochem 93 (2005) 1220-1230
20. Kirsch J. Glycinergic transmission. Cell Tissue Res 326 (2006) 535-540
21. Kontinen V.K., Stanfa L.C., Basu A., and Dickenson A.H. Electrophysiologic evidence for increased endogenous gabaergic but not glycinergic inhibitory tone in the rat spinal nerve ligation model of neuropathy. Anesthesiology 94 (2001) 333-339
22. Legendre P. The glycinergic inhibitory synapse. Cell Mol Life Sci 58 (2001) 760-793
23. Lynch J.W. Molecular structure and function of the glycine receptor chloride channel. Physiol Rev 84 (2004) 1051-1095
24. Madin A., O'Donnell C.J., Oh T., Old D.W., Overman L.E., and Sharp M.J. Total synthesis of (+/-)-gelsemine. Angew Chem Int Ed Engl 38 (1999) 2934-2936
25. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 38 (1992) 379-395
26. Maksay G., Laube B., and Betz H. Subunit-specific modulation of glycine receptors by neurosteroids. Neuropharmacology 41 (2001) 369-376
27. McCool B.A., and Chappell A. Strychnine and taurine modulation of amygdala-associated anxiety-like behavior is 'state' dependent. Behav Brain Res 178 (2007) 70-81
28. Mellon S.H., and Griffin L.D. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab 13 (2002) 35-43
29. Mensah-Nyagan A.G., Feuilloley M., Dupont E., Do-Rego J.L., Leboulenger F., Pelletier G., and Vaudry H. Immunocytochemical localization and biological activity of 3 beta-hydroxysteroid dehydrogenase in the central nervous system of the frog. J Neurosci 14 (1994) 7306-7318
30. Mensah-Nyagan A.G., Do-Rego J.L., Feuilloley M., Marcual A., Lange C., Pelletier G., and Vaudry H. In vivo and in vitro evidence for the biosynthesis of testosterone in the telencephalon of the female frog. J Neurochem 67 (1996) 413-422
31. Mensah-Nyagan A.G., Feuilloley M., Do-Rego J.L., Marcual A., Lange C., Tonon M.C., Pelletier G., and Vaudry H. Localization of 17beta-hydroxysteroid dehydrogenase and characterization of testosterone in the brain of the male frog. Proc Natl Acad Sci U S A 93 (1996) 1423-1428
32. Mensah-Nyagan A.G., Do-Rego J.L., Beaujean D., Luu-The V., Pelletier G., and Vaudry H. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol Rev 51 (1999) 63-81
33. Mensah-Nyagan A.G., Beaujean D., Luu-The V., Pelletier G., and Vaudry H. Anatomical and biochemical evidence for the synthesis of unconjugated and sulfated neurosteroids in amphibians. Brain Res Brain Res Rev 37 (2001) 13-24
34. Mensah-Nyagan A.G., Do-Rego J.L., Beaujean D., Luu-The V., Pelletier G., and Vaudry H. Regulation of neurosteroid biosynthesis in the frog diencephalon by GABA and endozepines. Horm Behav 40 (2001) 218-225
35. Ng F.W., Lin H., Chiu P., and Danishefsky S.J. Explorations in organic chemistry leading to the total synthesis of (+/-)-gelsemine. J Am Chem Soc 124 (2002) 9812-9824
36. Normington K., and Russell D.W. Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions. J Biol Chem 267 (1992) 19548-19554
37. +-independent binding of [3H]beta-alanine to rat brain stem-spinal cord. Neurochem Res 13 (1988) 1133-1138
38. Ozturk C., Aviyente V., and Houk K.N. Modeling the stereoselectivity of the Johnson-Claisen rearrangements in the Danishefsky synthesis of gelsemine. J Org Chem 70 (2005) 7028-7034
39. Park-Chung M., Wu F.S., and Farb D.H. 3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons. Mol Pharmacol 46 (1994) 146-150
40. Patte-Mensah C., Kappes V., Freund-Mercier M.J., Tsutsui K., and Mensah-Nyagan A.G. Cellular distribution and bioactivity of the key steroidogenic enzyme, cytochrome P450side chain cleavage, in sensory neural pathways. J Neurochem 86 (2003) 1233-1246
41. Patte-Mensah C., Li S., and Mensah-Nyagan A.G. Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain-cleavage in sensory neural networks. Cell Mol Life Sci 61 (2004) 2274-2284
42. Patte-Mensah C., Penning T.M., and Mensah-Nyagan A.G. Anatomical and cellular localization of neuroactive 5 alpha/3 alpha-reduced steroid-synthesizing enzymes in the spinal cord. J Comp Neurol 477 (2004) 286-299
43. Patte-Mensah C., Kibaly C., and Mensah-Nyagan A.G. Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception. Proc Natl Acad Sci U S A 102 (2005) 9044-9049
44. Patte-Mensah C., Kibaly C., Boudard D., Schaeffer V., Begle A., Saredi S., Meyer L., and Mensah-Nyagan A.G. Neurogenic pain and steroid synthesis in the spinal cord. J Mol Neurosci 28 (2006) 17-31
45. Patte-Mensah C., and Mensah-Nyagan A.G. Peripheral neuropathy and neurosteroid formation in the central nervous system. Brain Res Rev (2007) 2007, Jun 9; [Epub ahead of print] doi: 10.1016/j.brainresrev.2007.05.007
46. Pellicer F., Lopez-Avila A., Coffeen U., Manuel Ortega-Legaspi J., and Angel R.D. Taurine in the anterior cingulate cortex diminishes neuropathic nociception: a possible interaction with the glycine(A) receptor. Eur J Pain 11 (2007) 444-451
47. Penning T.M., Mukharji I., Barrows S., and Talalay P. Purification and properties of a 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs. Biochem J 222 (1984) 601-611
48. Pinna G., Costa E., and Guidotti A. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology (Berl) 186 (2006) 362-372
49. Roglio I., Giatti S., Pesaresi M., Bianchi R., Cavaletti G., Lauria G., Garcia-Segura L.M., and Melcangi R.C. Neuroactive steroids and peripheral neuropathy. Brain Res Rev (2007) 2007, May 6; [Epub ahead of print] doi: 10.1016/j.brainresrev.2007.04.010
50. Schaeffer V., Patte-Mensah C., Eckert A., and Mensah-Nyagan A.G. Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins. J Neurobiol 66 (2006) 868-881
51. Schmieden V., Kuhse J., and Betz H. A novel domain of the inhibitory glycine receptor determining antagonist efficacies: further evidence for partial agonism resulting from self-inhibition. Mol Pharmacol 56 (1999) 464-472
52. Schumacher M., Robel P., and Baulieu E.E. Development and regeneration of the nervous system: a role for neurosteroids. Dev Neurosci 18 (1996) 6-21
53. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., and Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 95 (1998) 3239-3244
54. Uzunova V., Sampson L., and Uzunov D.P. Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action. Psychopharmacology (Berl) 186 (2006) 351-361
55. Weir C.J., Ling A.T., Belelli D., Wildsmith J.A., Peters J.A., and Lambert J.J. The interaction of anaesthetic steroids with recombinant glycine and GABAA receptors. Br J Anaesth 92 (2004) 704-711
56. Wu F.S., Gibbs T.T., and Farb D.H. Inverse modulation of gamma-aminobutyric acid- and glycine-induced currents by progesterone. Mol Pharmacol 37 (1990) 597-602
57. Yokoshima S., Tokuyama H., and Fukuyama T. Enantioselective total synthesis of (+)-gelsemine: determination of its absolute configuration. Angew Chem Int Ed Engl 39 (2000) 4073-4075
58. Zeilhofer H.U. The glycinergic control of spinal pain processing. Cell Mol Life Sci 62 (2005) 2027-2035